McNeil implements corrective action plan

By Modern Materials Handling Staff
April 01, 2010 - MMH Editorial

In the wake of a product recall that included more than 50 million units of Tylenol arthritis products, St. Joseph's Aspirin, Motrin and other products, the McNeil Consumer Healthcare unit of Johnson & Johnson reported that it has taken steps to ensure that similar situations do not happen in the future. In a letter to the U.S. Food and Drug Administration, Peter Luther, McNeil president, wrote, “McNeil and Johnson & Johnson management are taking this issue very seriously and are committed to ensuring that McNeil implements all necessary corrective and preventive actions to improve the McNeil quality systems.” The letter also outlined key elements of the corrective action plan that includes enhancements to the quality system, organizational changes, and senior management oversight. For more, go to Modern's Web site, mmh.com/recall.



Subscribe to Modern Materials Handling magazine

Subscribe today. It's FREE!
Find out what the world's most innovative companies are doing to improve productivity in their plants and distribution centers.
Start your FREE subscription today!

Recent Entries

Facility maintained an incidence rate at least 50% below the industry standard.

Jimenez began his career at Toyota as a college intern in the summer of 1996.

Batch led STEM initiatives beginning at the middle school level in engineering, multi-skill maintenance and production.

Machine vision systems and components grew 22% in the first quarter.

Survey highlights the growth of direct-from-manufacturer purchasing, B2B e-commerce, and a Millennial workforce.

Article Topics

Features · Up Front · Packaging · Pallets · All topics

Comments

Post a comment
Commenting is not available in this channel entry.


© Copyright 2015 Peerless Media LLC, a division of EH Publishing, Inc • 111 Speen Street, Ste 200, Framingham, MA 01701 USA